In this preliminary translational study, to our knowledge, we are among the first reporting a pilot EMT gene profile of CD45−CD146+ABCB5+ CMCs obtained from advanced melanoma patients at onset and then both in disease progression and clinical remission status. The gene discussed is ABCB5; the disease is melanoma.